Tsai Wei-Lun, Lo Gin-Ho, Hsu Ping-I, Lai Kwok-Hung, Lin Chiun-Ku, Chan Hoi-Hung, Chen Wen-Chi, Cheng Jin-Shiung, Liu Yung-Ching, Huang Tsi-Shu, Ger Luo-Ping, Lin Hsi-Hsun
Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Scand J Gastroenterol. 2008;43(2):196-201. doi: 10.1080/00365520701745693.
The results of long-term, follow-up studies show that the severity and frequency of acute exacerbation of chronic hepatitis B virus (HBV) are associated with the development of liver cirrhosis in chronic HBV infection. The aim of this study was to investigate the relationship between virological factors of HBV and the severity of acute exacerbation.
Fifty-one chronic hepatitis B patients with symptomatic acute exacerbation without antiviral therapy were enrolled in the study. Genotype of HBV was determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Precore (A1896) and basal core promoter (BCP) mutations (T1762 & A1764) were determined by PCR and direct sequencing.
Thirty-nine patients had genotype B, 11 patients had genotype C, and 1 patient had an unclassified genotype. Thirty-two patients had precore mutation and 24 patients had BCP mutation. After adjusting for age, gender, aspartate aminotransferase (ASAT) level, albumin level, and platelet count by multiple logistic regression test, precore mutation had a protective effect on the occurrence of hepatic decompensation (p=0.046), and genotype and BCP mutations were not associated with the occurrence of hepatic decompensation.
HBV precore mutation may confer less severe liver disease during acute exacerbation of chronic HBV. Genotype and BCP mutations did not have a significant association with the occurrence of hepatic decompensation.
长期随访研究结果表明,慢性乙型肝炎病毒(HBV)急性加重的严重程度和频率与慢性HBV感染患者肝硬化的发生有关。本研究旨在探讨HBV病毒学因素与急性加重严重程度之间的关系。
51例有症状的慢性乙型肝炎急性加重且未接受抗病毒治疗的患者纳入本研究。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)法测定HBV基因型。采用PCR和直接测序法检测前核心区(A1896)和基本核心启动子(BCP)突变(T1762&A1764)。
39例患者为B基因型,11例为C基因型,1例为未分类基因型。32例患者有前核心区突变,24例患者有BCP突变。通过多因素logistic回归分析校正年龄、性别、天冬氨酸转氨酶(ASAT)水平、白蛋白水平和血小板计数后,前核心区突变对肝失代偿的发生有保护作用(p=0.046),基因型和BCP突变与肝失代偿的发生无关。
HBV前核心区突变可能使慢性HBV急性加重期肝病的严重程度减轻。基因型和BCP突变与肝失代偿的发生无显著相关性。